Diabetes and Inflammation Laboratory. (360G-Wellcome-107212_Z_15_Z)
Our goal is to identify clinical interventions in patients recently diagnosed with, or children at high risk of developing, type 1 diabetes (T1D), thereby maximising the health benefits of genetics and genomics in this common immune disorder. Our studies in T1D serve as a model for the investigation of other diseases and their treatment. We will take specific steps towards achieving this goal during the next five year programme: (1) Genetics. Define the genetic basis of T1D by fine-mapping di sease-associated causal variants and haplotypes, identify their target genes, and investigate the regulation of these genes before and after cell activation/differentiation. (2) Phenotypes and mechanisms. Identify aberrant cellular interactions and pathways caused by susceptibility genes that mediate a loss of immune tolerance to insulin-producing beta cells culminating in their destruction. These will provide potential targets for therapeutic intervention, as demonstrated by our work in the I L-2 pathway. (3) Experimental medicine. Complete our mechanistic investigations of the effects of IL-2 administration in patients, as a prelude to testing the efficacy of ultra-low dose IL-2 in the preservation of C-peptide and beta-cell function. Investigate, using the same mechanistic approach and depending on our emerging knowledge, another potential therapeutic.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
Amount Awarded | 8289795 |
Applicant Surname | Todd |
Approval Committee | Strategic Awards Committee |
Award Date | 2015-04-21T00:00:00+00:00 |
Financial Year | 2014/15 |
Grant Programme: Title | Strategic Award - Science |
Internal ID | 107212/Z/15/Z |
Lead Applicant | Prof John Todd |
Other Applicant(s) | Dr Chris Wallace, Dr Frank Waldron-Lynch, Prof Linda Wicker |
Partnership Value | 8289795 |
Planned Dates: End Date | 2018-01-22T00:00:00+00:00 |
Planned Dates: Start Date | 2015-10-01T00:00:00+00:00 |
Recipient Org: Country | United Kingdom |
Region | East of England |